Recommendations for first-line antihypertensive drugs and combination therapies Osamu Iimura Invited Commentary Pages: 421 - 422
Major cardiovascular events in hypertensive patients randomized to doxazosin versus chlorthalidone Norman M. KaplanDonald G. Vidt Clinical trials report Pages: 431 - 431
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure Norman M. KaplanDonald G. Vidt Clinical trials report Pages: 432 - 432
The need to lower systolic blood pressure Sanjay ShrivastavaMahendr S. Kochar OriginalPaper Pages: 433 - 440
Treatment of hypertension in the hemodialysis patient: Beneficial or not? Mahmoud M. Salem OriginalPaper Pages: 441 - 444
Barriers to hypertension care and control Martha N. HillBrad S. Sutton OriginalPaper Pages: 445 - 450
Spironolactone in congestive heart failure Judith E. SobermanKarl T. Weber OriginalPaper Pages: 451 - 456
Optimal strategies for preventing progression of renal disease: Should angiotensin converting enzyme inhibitors and angiotensin receptor blockers be used together? Radko KomersSharon Anderson OriginalPaper Pages: 465 - 472
How aggressively should blood pressure be treated in renal transplant recipients? David K. Klassen OriginalPaper Pages: 473 - 477
Atherosclerotic renal artery stenosis: Surgery, percutaneous transluminal angioplasty, or medical therapy? Pierre-François PlouinBruno GuéryAgnès La Batide Alanore OriginalPaper Pages: 482 - 489
Circadian rhythm of blood pressure in renal disease Michael SchömigVedat SchwengerEberhard Ritz OriginalPaper Pages: 490 - 494
